Mirati Therapeutics (MRTX) PT Lowered to $72 at BofA Securities After ASCO
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on Mirati Therapeutics (NASDAQ: MRTX) to $72.00 (from $82.00) after shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
